The FDA assigned a Prescription Drug User Fee Act (PDUFA) date of April 2, 2025, for reproxalap for patients with dry eye ...
A 25-year-old woman with vitiligo universalis, a severe form of vitiligo that causes nearly complete loss of skin color ...
The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback